Skip to main content
OpenTrials

Clinical trial condition

Pasteurellaceae Infections

Explore clinical trials studying Pasteurellaceae Infections. Study availability and eligibility vary by location and protocol.

162 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Pasteurellaceae Infections trial results

Completed

A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers

NCT04535037

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +19 more
Locations
  • GSK Investigational Site Rosenheim, Bavaria, Germany
  • GSK Investigational Site Schönau am Königssee, Bavaria, Germany
  • GSK Investigational Site Leipzig, Brandenburg, Germany
  • GSK Investigational Site Wolfsburg, Lower Saxony, Germany
View all 20 locations
View Trial Details
Completed

Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study)

NCT04978818

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Alaska Native Medical Center Anchorage, Alaska, United States
  • Chinle Center for Indigenous Health Chinle, Arizona, United States
  • Fort Defiance Center for Indigenous Health Fort Defiance, Arizona, United States
  • Gallup Center for Indigenous Health Gallup, New Mexico, United States
View Trial Details
Completed

Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth

NCT02428491

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +36 more
Locations
  • Preventive Medicine Centre of Thai Binh Province Thái Bình, Vietnam
View Trial Details
Completed

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine 2830930A Administered in Toddlers

NCT01485406

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +6 more
Locations
  • GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
  • GSK Investigational Site Berchtesgaden, Bavaria, Germany
  • GSK Investigational Site Braunatal, Hesse, Germany
  • GSK Investigational Site Berlin, Germany
View Trial Details

Related conditions